Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fatma Aydogan"'
Publikováno v:
Molecular and Clinical Oncology. 3:954-958
Breast cancer is a complex disease displaying different profiles involving genetic as well as epigenetic factors. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression. Recent studies demonstrated that miRNAs may display great p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8561c8509e82254cbed1d62061311df7
https://doi.org/10.3892/mco.2015.567
https://doi.org/10.3892/mco.2015.567
Autor:
Ibrahim Yildiz, Leyla Kilic, Faruk Aykan, Fatma Aydogan, Serkan Keskin, Fatma Sen, Sezer Saglam, Meltem Ekenel, Burak Sakar, Rian Disci
Publikováno v:
Clinical and Translational Oncology. 15:403-408
The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy-naïve AGC patients.Patients (n = 54) with locally inoperable or distant metastasis and perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df94a6b4f83b8decda5cbe9f4d69a856
https://doi.org/10.1007/s12094-012-0942-8
https://doi.org/10.1007/s12094-012-0942-8
Autor:
Murat Emin Guveli, Mahmut Muslumanoglu, Fatma Aydogan, Erkan Topuz, Vahit Ozmen, Yesim Eralp, Abdullah Igci, Adnan Aydiner, Pinar Saip, Serkan Keskin, Esmehan Pehlivan, Ekrem Yavuz, Hasan Karanlik
Publikováno v:
Oncology. 81(1)
Objective: Patients with breast cancer with a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) have a better prognosis than patients with residual disease. The aim of the current study was to identify predictors of pCR. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9be73e8e736f92517b7e37697b44ca
https://pubmed.ncbi.nlm.nih.gov/21912195
https://pubmed.ncbi.nlm.nih.gov/21912195
Autor:
Halil Alis, Sezai Vatansever, Mehmet Karabulut, Senem Karabulut, Nuri Faruk Aykan, Koray Celebi, Hamza Ugur Bozbey, Kayhan Erturk, Fatma Aydogan
Publikováno v:
Journal of Clinical Oncology. 33:e14533-e14533
e14533 Background: Claudin-7 (CLDN7) belongs to the claudin family which consists of 24 subtypes of essential tight junction integral membrane proteins with molecular weights of 20-27 kDa. Tight ju...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3996eb0991eb1d287ae2c3e4886c5a38
https://doi.org/10.1200/jco.2015.33.15_suppl.e14533
https://doi.org/10.1200/jco.2015.33.15_suppl.e14533
Autor:
Sezer Saglam, Leyla Kilic, Meltem Ekenel, Burak Sakar, Serkan Keskin, Rian Disci, Faruk Aykan, Fatma Sen, Fatma Aydogan
Publikováno v:
Journal of Clinical Oncology. 30:e14628-e14628
e14628 Background: The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy naïve AGC patients. Methods: Patients (n=54) with locally inoperable or di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b46c474d28eefb98cc1367a059fccf2
https://doi.org/10.1200/jco.2012.30.15_suppl.e14628
https://doi.org/10.1200/jco.2012.30.15_suppl.e14628
Autor:
Fatma Aydogan, Faruk Tas, Mehmet Karabulut, Cigdem Usul Afsar, Senem Karabulut, Halil Alis, Mehmet Abdussamet Bozkurt, Murat Serilmez
Publikováno v:
BBA Clinical
Background Omentin is related with metabolic syndrome and obesity. Pancreatic adenocarcinoma (PA) is a lethal and obesity-linked malignancy. This study was conducted to investigate the serum levels of omentin in patients with PA and the relationship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3b7aa6c0888e84c14d1b2e1761b6fe
Autor:
Pınar Saip, Serkan Keskin, Metin Özkan, Mehmet Ali Kaplan, Fatma Aydoğan, Güzin Gönüllü Demirağ, Sernaz Uzunoğlu, Hüseyin Engin, Gül Başaran, Nilüfer Güler, Kazım Uygun, Binnaz Demirkan, Feyyaz Özdemir, Erdem Çubukçu, Taflan Salepçi, İrfan Çiçin
Publikováno v:
European Journal of Breast Health, Vol 7, Iss 2, Pp 109-117 (2011)
Purpose:We aimed to determine the elapsed time between the first notification of the disease and the accession to the diagnosis and treatment modalities and its associated factors in female patients with breast cancer in Turkey.Patients and Methods:T
Externí odkaz:
https://doaj.org/article/9c88287d3f0748bda34bb4403a75c41c